Curis appoints Jaye Viner as Chief Medical Officer Curis announced the appointment of Doctor Jaye Viner as Chief Medical Officer and executive vice president. Viner will be responsible for the leadership of Curis' clinical development strategy and efforts to further the development of its pipeline of proprietary drug candidates. Since April 2012, Viner served as a Medical Director at Millennium, The Takeda Oncology company. In addition to Viner's appointment, Curis also announced the appointment of Tania Chander as vice president of product development. Chander comes from MedImmune, a subsidiary of AstraZeneca.
News For CRIS From The Last 14 Days
Check below for free stories on CRIS the last two weeks.